Sumitomo Life Insurance Co. Has $1.25 Million Holdings in The Allstate Co. (NYSE:ALL)

Sumitomo Life Insurance Co. boosted its stake in The Allstate Co. (NYSE:ALL) by 0.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,567 shares of the insurance provider’s stock after buying an additional 61 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in Allstate were worth $1,245,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. Rise Advisors LLC acquired a new stake in shares of Allstate in the 1st quarter valued at $26,000. Northwest Investment Counselors LLC bought a new stake in Allstate during the first quarter worth about $26,000. Versant Capital Management Inc increased its holdings in shares of Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new stake in shares of Allstate during the second quarter worth approximately $38,000. Finally, MCF Advisors LLC raised its stake in shares of Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after acquiring an additional 84 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Trading Up 1.4 %

Shares of Allstate stock opened at $195.64 on Thursday. The Allstate Co. has a 1 year low of $121.70 and a 1 year high of $195.87. The company has a market capitalization of $51.63 billion, a price-to-earnings ratio of 43.19, a P/E/G ratio of 1.74 and a beta of 0.48. The business has a fifty day simple moving average of $185.67 and a two-hundred day simple moving average of $173.49. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion during the quarter, compared to the consensus estimate of $14.04 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. Allstate’s revenue was up 12.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($4.42) EPS. Research analysts forecast that The Allstate Co. will post 15.19 EPS for the current year.

Insider Activity

In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Elizabeth Brady sold 49,481 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now directly owns 19,163 shares in the company, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is owned by insiders.

Analysts Set New Price Targets

ALL has been the topic of several research analyst reports. Piper Sandler increased their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a report on Friday, August 16th. Raymond James boosted their target price on shares of Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 4th. Barclays started coverage on shares of Allstate in a report on Wednesday, September 4th. They issued an “underweight” rating and a $175.00 price target for the company. JPMorgan Chase & Co. upped their price objective on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, The Goldman Sachs Group lifted their target price on Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $201.06.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.